PREDICINE

Predicine is a molecular information company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. It has developed a portfolio of regulated liquid biopsy genomic products to help advance the science of precision medicine in cancer. The company offers 600 gene-panel to facilitate biomarker-driven patient enrollment in clinical trials. Predicine's biology-oriented approach to analyzing genomics is advancing the understanding of tumor mutational landscape. With its vast data sets and advanced analytics, Predicine partners with 30+ biopharma to support their clinical trials in the US, EU, Australia, and China.